CAS: 2349368-16-5
Ref: 54-BUP08753
| 25mg | 675.00 € | ||
| 50mg | 946.00 € | ||
| 100mg | 1,173.00 € | ||
| 500mg | 2,289.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
![2-(4-Ethylsulfonylphenyl)-N-[4-[2-fluoro-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]phe…](https://static.cymitquimica.com/products/3D/thumb/ZTD36816.jpg)
2-(4-Ethylsulfonylphenyl)-N-[4-[2-fluoro-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]phenyl]acetamide
CAS:2349368-16-5
Please enquire for more information about 2-(4-Ethylsulfonylphenyl)-N-[4-[2-fluoro-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]phenyl]acetamide including the price, delivery time and more detailed …
Formula:
C25H20F7NO4S
Purity:
Min. 95%
Molecular weight:
563.5 g/mol
Ref: 3D-ZTD36816
| 25mg | 1,262.00 € | ||
| 50mg | 1,755.00 € |
Estimated delivery in United States, on Monday 16 Jun 2025
XY101
CAS:2349368-16-5
XY101 is a selective, metabolically stable and orally available agonist of RORγ inverse(IC50 of 30 …
Formula:
C25H20F7NO4S
Purity:
98.81%
Color and Shape:
Solid
Molecular weight:
563.48
Ref: TM-T13362
| 1mg | 87.00 € | ||
| 5mg | 170.00 € | ||
| 10mg | 284.00 € | ||
| 25mg | 452.00 € | ||
| 50mg | 645.00 € | ||
| 100mg | 867.00 € | ||
| 500mg | 1,691.00 € | ||
| 1mL*10mM (DMSO) | 205.00 € |
Estimated delivery in United States, on Monday 23 Jun 2025
